Sign In
Buy HDV
$27.39
+0.360 (+1.33%)
At Close: Jun 23, 2026
Here's How Much You'd Need to Invest in HDV to Generate $500 per Month in Dividends
02:02pm, Tuesday, 23'rd Jun 2026
The iShares Core High Dividend ETF (HDV) targets high-yield stocks from a universe that meets multiple Morningstar quality measures. It currently pays a dividend that yields 3.0%.
SCHD vs. HDV: Which Dividend ETF Is the Better Buy for Long-Term Investors?
06:41am, Saturday, 20'th Jun 2026
The Schwab U.S. Dividend Equity ETF (SCHD) offers a lower expense ratio and a higher dividend yield than the iShares Core High Dividend ETF (HDV). HDV has delivered higher 5-year total returns and mai
Want Decades of Passive Income? Here Are 2 ETFs Worth Owning Forever.
12:45pm, Friday, 19'th Jun 2026
The Schwab U.S. Dividend Equity ETF considers balance sheet quality, dividend history, and yield to produce its portfolio. The iShares Core High Dividend ETF emphasizes balance sheet health and the hi
Is This Dividend ETF a Millionaire Maker?
06:45am, Thursday, 18'th Jun 2026
Investing in dividend stocks remains a great long-term strategy for building a retirement portfolio. The iShares Core High Dividend ETF (HDV) uses a smart portfolio-construction approach to identify f
Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced pivotal Phase 2 results from Cohort 1 of the PROGRESS study evaluating zilur
HDV: Less Stable Than SCHD With No Dividend Or Quality Advantage
12:08pm, Wednesday, 10'th Jun 2026
I assign iShares Core High Dividend ETF a neutral 'hold' rating due to elevated energy sector risk and only average dividend growth. HDV's 21.56% energy allocation has driven recent outperformance but
Is iShares Core High Dividend ETF (HDV) a Strong ETF Right Now?
07:22am, Wednesday, 10'th Jun 2026
Making its debut on 03/29/2011, smart beta exchange traded fund iShares Core High Dividend ETF (HDV) provides investors broad exposure to the Style Box - Large Cap Value category of the market.
Retirees: Here's Why HDV Makes More Sense Than JEPI for Your Income Portfolio
05:15am, Wednesday, 10'th Jun 2026
The JPMorgan Equity Premium Income ETF (JEPI) built its reputation on a strong year in 2022. Since then, it's trailed the S&P 500 badly, and its distribution yield has fallen significantly.
A 4.8 Percent Yield Portfolio That Lets a 72-Year-Old Sleep Through Every Quarterly Earnings Surprise
11:46am, Thursday, 04'th Jun 2026
The mechanics of retirement income are often simpler than the investment products marketed to provide it. A 72-year-old retiree with $1.1 million invested and an income goal of $52,800 per year, or $4
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Incyte (Nasdaq: INCY) today announced that pivotal Phase 2 results from the PROGRESS study evaluating zilurgiser
VYM vs. HDV: Which U.S. Dividend Stock ETF Is a Better Buy?
02:00am, Thursday, 04'th Jun 2026
Sometimes the exchange-traded fund with the most stocks wins.
HDV vs. FDVV: One of These High-Dividend ETFs Has a Surprising Secret
07:40am, Wednesday, 03'rd Jun 2026
iShares Core High Dividend ETF offers a more competitive expense ratio than Fidelity High Dividend ETF but has generated a lower total return over the past 12 months. Fidelity High Dividend ETF provid
Higher Yield or Broader Dividend Diversification? VYM vs. HDV
11:01pm, Tuesday, 02'nd Jun 2026
The Vanguard High Dividend Yield ETF (VYM) and the iShares Core High Dividend ETF (HDV) both provide exposure to U.S. dividend equities, but their income profiles are built differently. For investors
These 2 Dividend ETFs Are Beating the S&P 500 -- Which Should You Buy?
05:47am, Tuesday, 02'nd Jun 2026
A well-diversified dividend ETF should offer alternatives to AI stocks.
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
12:00pm, Saturday, 30'th May 2026
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced new data from its rare liver disease programs. Late-breaking result
